Healthcare
Live Price
Offline$11.72
-4.33% today
1Y Change
+86.93%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Palatin Technologies, Inc. (PTN) is a Healthcare stock with a market cap of $530.00M and listed on AMEX. The stock last traded around $11.72 and up 86.9% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of -1491.6%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS -1491.6%, free cash flow +32.4% with operating margin -134.8% and ROIC -102.3%. Valuation already assumes a fairly strong business story at price/sales 58.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PTN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PTN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PTN Max Drawdown
-71.32%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PTN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
-$188.6K
-112.8% YoY
FY Net Income
-$33.6M
+7.3% YoY
Free Cash Flow
-$22.7M
+24.9% YoY
Revenue Growth
-100.0%
EPS Growth
-1491.6%
Gross Margin
99.2%
Net Margin
-107.4%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 4M | 5M | 1M | -189K |
| Gross Profit | -259K | 4M | 4M | 1M | -336K |
| Operating Income | -23M | -22M | -32M | -37M | -33M |
| EBITDA | -17M | -29M | -28M | -36M | -34M |
| Net Income | -17M | -30M | -24M | -36M | -34M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3M | 10M | 8M | 30M | 60M |
| Total Assets | 3M | 11M | 18M | 36M | 67M |
| Total Liabilities | 8M | 11M | 20M | 20M | 18M |
| Shareholder Equity | -5M | -111K | -2M | 16M | 50M |
| Total Debt | 164K | 590K | 1M | 1M | 1M |
| Net Debt | -2M | -9M | -7M | -29M | -59M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
23M
+24.3% YoY
Capital Expenditures
6K
+97.8% YoY
Free Cash Flow
23M
+24.9% YoY
Key ratios
Gross Margin
99.2%
Operating Margin
-134.8%
Net Margin
-107.4%
ROE
-5515.1%
Debt / Equity
0.03x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.